Richard Bold, M.D., named site director, Mayo Clinic Comprehensive Cancer Center in Arizona
ROCHESTER, Minn. — Richard Bold, M.D., has been named site director of Mayo Clinic Comprehensive Cancer Center in Arizona. Dr. Bold joins Mayo Clinic from the University of California, Davis (UC Davis), the place he has constructed a powerful profession marked by excellence in affected person care, modern analysis and dynamic management. While at UC Davis, he served as affiliate medical technique officer, UC Davis Health; doctor in chief, UC Davis Comprehensive Cancer Center; government vice chair, Department of Surgery; professor, Division of Surgical Oncology; medical director, UC Davis Cancer Care Network; and the Isabelle J. McDonald Endowed Professor of Cancer Research.
“Mayo Clinic and Mayo Clinic Comprehensive Cancer Center are thrilled to have recruited Dr. Bold to this critical leadership role at Mayo Clinic in Arizona, and we are excited to work with him to continue to enhance cancer research, education and patient care in the Southwest and across the nation,” says Cheryl Willman, M.D., Stephen and Barbara Slaggie Enterprise Executive Director, Mayo Clinic Cancer Programs and Director, Mayo Clinic Comprehensive Cancer Center. “His track record of visionary leadership and dedication to patient-centric healthcare make him an exceptional choice to lead Mayo Clinic Comprehensive Cancer Center in Arizona.”
Throughout his profession, Dr. Bold has demonstrated a dedication to enhancing most cancers detection and intervention. His ardour for bringing main experience to every affected person, with analysis and training that ship innovation, aligns seamlessly with Mayo Clinic’s mission and values, making him a really perfect match for this position.
“As we embark on this new chapter with Dr. Bold at the helm, we are confident that his vision and expertise will lead Mayo Clinic Comprehensive Cancer Center in Arizona to even greater heights of excellence,” says Richard Gray, M.D., CEO, Mayo Clinic in Arizona. “His dedication to fostering collaboration, nurturing talent and driving innovation will undoubtedly inspire our teams to continue delivering the highest quality cancer care to our patients and community.”
Dr. Bold will start his new position on Oct. 2. He succeeds Alan Bryce, M.D., prior chair of the Division of Hematology/Oncology and interim site director of Mayo Clinic Comprehensive Cancer Center in Arizona.
Mayo Clinic was not too long ago ranked the No. 1 hospital in Arizona and the No. 1 cancer hospital in Arizona by U.S. News & World Report. With large development in Arizona, Mayo Clinic plans so as to add extra biomanufacturing capabilities and next-generation diagnostics by Discovery Oasis collaborations in the approaching years. These developments will speed up transformation and foster innovation to create the patient-centered way forward for healthcare.
